AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 176 filers reported holding AXSOME THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.46 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,394,852 | -2.7% | 248,889 | +0.0% | 0.23% | 0.0% |
| Q2 2023 | $17,876,756 | +74.1% | 248,772 | +49.4% | 0.23% | +56.9% |
| Q1 2023 | $10,270,028 | -42.9% | 166,505 | -28.6% | 0.14% | -46.3% |
| Q4 2022 | $17,978,617 | -9.4% | 233,095 | -3.4% | 0.27% | -44.5% |
| Q2 2020 | $19,853,000 | +28.5% | 241,284 | -8.1% | 0.48% | -6.4% |
| Q1 2020 | $15,445,000 | -45.8% | 262,541 | -4.8% | 0.52% | -31.9% |
| Q4 2019 | $28,498,000 | – | 275,717 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,123,929 | $42,462,000 | 36.04% |
| MORGAN JESS S & CO INC | 114,525 | $4,327,000 | 2.66% |
| Fairmount Funds Management LLC | 187,598 | $7,087,000 | 2.34% |
| WMS Partners, LLC | 242,500 | $9,162,000 | 1.95% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 610,064 | $23,048,000 | 1.41% |
| MANGROVE PARTNERS IM, LLC | 400,000 | $15,112,000 | 0.90% |
| RTW INVESTMENTS, LP | 1,618,819 | $61,159,000 | 0.89% |
| MPM BioImpact LLC | 103,405 | $3,907,000 | 0.71% |
| Avidity Partners Management LP | 775,000 | $29,280,000 | 0.62% |
| FIRST MIDWEST BANK TRUST DIVISION | 115,028 | $4,346,000 | 0.56% |